“The Company has completed the United States Food and Drug Administration (USFDA) inspection at its API’s manufacturing facility located at Sy. No.180/2, Kazipally, Jinnaram MandaI, Sangareddy district, Telangana (Unit I), without any observations,” the company said in the filing.
The inspection commenced on 04.04.2022 and concluded on April 08, 2022.
The stock is currently trading at Rs840.70 down by Rs34.25 or 3.91% from its previous closing of Rs874.95 on the BSE. The scrip opened at Rs869 and has touched a high and low of Rs869 and Rs828.95 respectively.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
